Results 41 to 50 of about 1,467 (85)

Dopaminergic progenitors generated by small molecule approach survived, integrated, and promoted functional recovery in (6-OHDA) mouse model of Parkinson's disease. [PDF]

J Neurol Sci
Alexanian AR, Sorokin A, Duersteler M.
europepmc   +1 more source

Genetically engineered BMSCs promote dopamine secretion and ameliorate motor dysfunction in a Parkinson's disease rat model. [PDF]

Sci Rep
Wang C, Liu Y, Chang J, He Y, Yang P, Fu J, Du W, Ma C, Liu G, Guo Y, Liu C.   +10 more
europepmc   +1 more source

Unconventional secretion of PARK7 requires lysosomal delivery via chaperone-mediated autophagy and specialized SNARE complex. [PDF]

Proc Natl Acad Sci U S A
Dash BK, Urano Y, Mita Y, Ashida Y, Hirose R, Noguchi N.   +5 more
europepmc   +1 more source

Neuroprotective Activity of Oligomeric Stilbenes from Alpha Grape Stems in In Vitro Models of Parkinson's Disease. [PDF]

Int J Mol Sci
Pislyagin EA, Tarbeeva DV, Yurchenko EA, Menchinskaya ES, Gorpenchenko TY, Pokhilo ND, Kalinovskiy AI, Aminin DL, Fedoreyev SA.   +8 more
europepmc   +1 more source

Genome-wide association study -Driven drug repositioning for the treatment of insomnia. [PDF]

J Genet Eng Biotechnol
Satria RD, Adikusuma W, Sukorini U, Avitasari DE, Kusuma Harahap IS, Setia Lesmana MH, Irham LM, Fatimah Harahap NI, Rinastiti P, Wardhana DA, Prabasaktya RW, Lin CF, Paramitasari A, Kusumadewi AF.   +13 more
europepmc   +1 more source

Stimulation of microneedles alleviates pathology of Parkinson's disease in mice by regulating the CD4+/CD8+ cells from the periphery to the brain. [PDF]

Front Immunol
Kim JH, Choi Y, Kim JS, Lee H, Ju IG, Yoo NY, La S, Jeong DH, Na C, Park HJ, Oh MS.   +10 more
europepmc   +1 more source

Identifying genetic targets in clinical subtypes of Parkinson's disease for optimizing pharmacological treatment strategies. [PDF]

Signal Transduct Target Ther
Kong D, Li C, Ma L, Du L, Jiang N, Zhao X, Zhang S, Zhao Z, Fang L, Du G.   +9 more
europepmc   +1 more source

A systematic exploration of unexploited genes for oxidative stress in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Suzuki T, Bono H.
europepmc   +1 more source

Insulin-Like Growth Factor Binding Protein 2 Drives Neurodegeneration in Parkinson's Disease: Insights From In Vivo and In Vitro Studies. [PDF]

CNS Neurosci Ther
An J, Wen L, Yu H, Bu Z, Feng J.
europepmc   +1 more source

Transient Increases in Neural Oscillations and Motor Deficits in a Mouse Model of Parkinson's Disease. [PDF]

Int J Mol Sci
Wu Y, Lu L, Qing T, Shi S, Fang G.
europepmc   +1 more source